Epstein-Barr virus (EBV) induced pneumonitis in an immunocompetent adult: A case report

Epstein Barr Virus (EBV) is one of the herpes viruses that is responsible for causing infectious mononucleosis, lymphomas, and carcinomas primarily in immunocompromised individuals. We present a case of EBV-induced pneumonitis in an immunocompetent female, successfully treated with steroids. The pat...

Full description

Saved in:
Bibliographic Details
Published in:Respiratory medicine case reports 2020-01, Vol.31, p.101262, Article 101262
Main Authors: Niazi, Muhammad Raphay, Iqbal, Qasim Zafar, Mishiyev, Danil, Narula, Naureen, Abdul Sattar, Saud Bin, Zia, Zeeshan, Haider, Muhammad Adnan, Chalhoub, Michel
Format: Article
Language:English
Subjects:
Case Report
Epstein-barr virus
Internal medicine
Pulmonary disease
Rheumatoid arthritis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Epstein Barr Virus (EBV) is one of the herpes viruses that is responsible for causing infectious mononucleosis, lymphomas, and carcinomas primarily in immunocompromised individuals. We present a case of EBV-induced pneumonitis in an immunocompetent female, successfully treated with steroids. The patient is a 70 year-old female with a history of infectious mononucleosis in her teens who presented to the emergency room with worsening shortness of breath, associated with cough and fever. She underwent extensive work up and her serologic workup revealed positive anti-EBV antibodies, pointing towards the diagnosis of EBV induced pneumonitis. EBV-induced Pneumonitis is a very rare entity and is especially hardly seen among immunocompetent individuals. This interesting case shows that in this new era of viral pneumonias, EBV induced pneumonitis should be considered among differentials when dealing with lung infections. Prompt initiation of treatment with steroids or antiviral medication may result in complete recovery. The choices among treatment options can be individualized according to the severity of disease, course of disease progression, and side effect profile of medications. In our case we were able to successfully treat the patient with high dose steroids only.
ISSN:2213-0071
2213-0071
DOI:10.1016/j.rmcr.2020.101262